December 24, 2013 — Clinical trials for a promising new class of cholesterol-lowering medications, a long-awaited repair ...
Hypertension
This page includes news and new technology on hypertension. The condition is caused by abnormally high blood pressure that causes excess force and pressure of the blood against the artery walls. Long-term, this can cause damage the vessels and contributes to heart disease. Therapies include antihypertensive medications such as diurestics and renal denervation therapy.
December 6, 2013 — Medtronic Inc. announced CE mark in Europe and Therapeutic Goods Administration (TGA) listing in ...
December 06, 2013
December 6, 2013 – Medtronic, Inc. presented three-year data from SYMPLICITY HTN-2, the first and longest-running ...
December 06, 2013
Feature | Dave Fornell
The use of renal stenting in combination with medication-based therapy to treat hypertension showed no improvement in ...
November 19, 2013November 13, 2013 — Petr Neuzil, M.D., Nemocnice Na Homolce Hospital, Prague, Czech Republic, presented three-month ...
November 13, 2013
November 13, 2013 — Medtronic Inc. announced that the U.S. Food and Drug Administration (FDA) has approved an ...
November 13, 2013
November 8, 2013 — A new way of using blood pressure-lowering medications could prevent more than a fourth of heart ...
November 08, 2013
October 31, 2013 — Patients treated with the Boston Scientific Vessix Renal Denervation System experienced a significant ...
October 31, 2013October 28, 2013 — CBSET, a not-for-profit preclinical research institute dedicated to biomedical research, education ...
October 28, 2013
October 25, 2013 — Kona Medical Inc. announced it has closed a Series D equity financing of $10 million. Morningside ...
October 25, 2013
October 14, 2013 — Since its debut in 2010, the renal denervation market has generated enthusiasm across the medical ...
October 14, 2013
September 27, 2013 — Rox Medical has crossed the halfway point in the CONTROL-HTN international, multi-center ...
September 27, 2013September 9, 2013 -- Among patients with prehypertension and coronary artery disease, use of the renin (an enzyme ...
September 09, 2013
September 3, 2013 — St. Jude Medical Inc. announced the CE mark approval of its next-generation EnligHTN renal ...
September 03, 2013
August 22, 2013 — Qinghui Chen, assistant professor in Michigan Tech’s kinesiology and integrative physiology department ...
August 22, 2013© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now